Related Experiment Video
Updated: Apr 21, 2026

06:21
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
1.6K
Microarray and next-generation sequencing to analyse gastric cancer
Yuan Dang1, Ying-Chao Wang, Qiao-Jia Huang
1Department of Experimental Medicine, Fuzhou General Hospital (Dongfang Hospital), Fuzhou, China
Asian Pacific Journal of Cancer Prevention : APJCP
|October 24, 2014
Summary
Gastric cancer research uses microarray and next-generation sequencing (NGS) to find new treatments. These technologies help identify molecular targets for personalized gastric cancer therapies, though challenges remain in clinical application.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Gastric cancer is a leading cause of cancer mortality worldwide.
- Early detection and targeted treatments are crucial for improving patient survival.
- Advanced genomic technologies are transforming gastric cancer research.
Purpose of the Study:
- To review insights from microarray and next-generation sequencing (NGS) in gastric cancer research.
- To discuss the elucidation of the molecular basis of gastric cancer.
- To identify potential therapeutic targets and analyze candidate genes.
Main Methods:
- Review of studies utilizing microarray technology for functional genomics and systems biology.
- Analysis of applications of next-generation sequencing (NGS) in genome, epigenetics, and functional genomics.
- Examination of methods for analyzing candidate genes in gastric cancer.
Main Results:
- Microarray and NGS technologies provide comprehensive insights into gastric cancer molecular mechanisms.
- These technologies facilitate the identification of potential therapeutic targets and biomarkers.
- Challenges exist in translating discoveries into clinical benefits for gastric cancer patients.
Conclusions:
- Microarray and NGS are powerful tools for advancing gastric cancer research and personalized medicine.
- Further efforts are needed to overcome challenges in target discovery and clinical implementation.
- Future directions involve refining these technologies for broader clinical application in gastric cancer treatment.

